| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 5111 | 6-MOMO-BTA-0 (GMP) |
5111.0005: 5 mg per vial
Please inquire for customized filling and bulk quantities. 
|
|
Precursor for [N-Methyl-11C]-6-OH-BTA-1
|
||
| Manufactured according to GMP requirements for APIs for use in clinical trials (ICH Q7 chapter 19) | ||
| Molar Mass: 286.35 | ||
| C15H1N2OS | ||
| [566170-03-4] | ||
| Colourless to yellowish solid packaged in dark glass crimp cap vials. | ||
| Purity: ≥ 97 % | ||
|
Certificates:
CoA with NMR spectra (identity); HPLC (purity); GC (residual solvents, water content); Content Palladium and Copper (AAS); microbiology test |
||
|
Chemical Name: CA index name: Benzenamine, 4-[6-(methoxymethoxy)-2-benzothiazolyl]- |
||
|
Synonymes: 2-(4′-Aminophenyl)-6-methoxymethoxybenzothiazole; Pittsburgh Compound B (PiB)-MOM-precursor |
||
|
Literature: Same as product number 5110. |
||
| date of product catalogue issue: 10 May 2017 | ||